MDGL - Madrigal Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MDGL is currently covered by 12 analysts with an average price target of $526.76. This is a potential upside of $86.83 (19.74%) from yesterday's end of day stock price of $439.93.

Madrigal Pharmaceuticals's activity chart (see below) currently has 149 price targets and 136 ratings on display. The stock rating distribution of MDGL is 90.48% BUY, 7.14% HOLD and 2.38% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 92.59% with an average time for these price targets to be met of 454.69 days.

Highest price target for MDGL is $526, Lowest price target is $392, average price target is $443.82.

Most recent stock forecast was given by EDWARD NASH from CANACCORD on 12-Sep-2025. First documented stock forecast 29-Oct-2014.

Currently out of the existing stock ratings of MDGL, 38 are a BUY (90.48%), 3 are a HOLD (7.14%), 1 are a SELL (2.38%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$526

$86.07 (19.56%)

$428

8 days ago
(12-Sep-2025)

14/15 (93.33%)

$93.78 (21.70%)

378

Buy

$485

$45.07 (10.24%)

$443

1 months ago
(20-Aug-2025)

13/14 (92.86%)

$93.34 (23.83%)

409

Buy

$523

$83.07 (18.88%)

$441

1 months 8 days ago
(12-Aug-2025)

3/4 (75%)

$164 (45.68%)

507

Buy

$460

$20.07 (4.56%)

$422

4 months 18 days ago
(02-May-2025)

11/14 (78.57%)

$144.52 (45.81%)

253

Buy

$405

$-34.93 (-7.94%)

$400

6 months 24 days ago
(27-Feb-2025)

18/18 (100%)

$49.12 (13.80%)

287

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MDGL (Madrigal Pharmaceuticals) average time for price targets to be met?

On average it took 454.69 days on average for the stock forecasts to be realized with a an average price target met ratio 92.59

Which analyst has the current highest performing score on MDGL (Madrigal Pharmaceuticals) with a proven track record?

JONATHAN WOLLEBEN

Which analyst has the most public recommendations on MDGL (Madrigal Pharmaceuticals)?

Jonathan Wolleben works at JMP and has 10 price targets and 8 ratings on MDGL

Which analyst is the currently most bullish on MDGL (Madrigal Pharmaceuticals)?

Andrea Tan with highest potential upside - $125.07

Which analyst is the currently most reserved on MDGL (Madrigal Pharmaceuticals)?

Matthew Luchini with lowest potential downside - -$328.93

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?